Suchergebnisse - "Silberstein, Stephen D"

PubPharm (498)

1

How early can we treat migraine attacks? A perspective based on prodrome

enthalten in: Med (New York, N.Y.) | 2024

von Yuan, H. | Silberstein, S.

2

Evidence-based preventive treatment of migraine

enthalten in: Handbook of clinical neurology | 2024

von Duncan, C. | Silberstein, S.

3

Drug-Free Noninvasive Thermal Nerve Block : Validation of Sham Devices

enthalten in: Brain sciences | 2023

von Fishman, M. | Chitneni, A. | Abd-Elsayed, A. | +10

4

Treatment of chronic migraine with Botox (onabotulinumtoxinA) : Development, insights, and impact

enthalten in: Medicine | 2023

von Turkel, C. | Aurora, S. | Diener, H. | +4

5

Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse : A subgroup analysis

enthalten in: Headache | 2023

von Tepper, S. | Lipton, R. | Silberstein, S. | +8

6

Current and emerging pharmacotherapy for menstrual migraine : a narrative review

enthalten in: Expert opinion on pharmacotherapy | 2023

von Ceriani, C. | Silberstein, S.

7

Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch : A Retrospective Analysis Using the FDA Adverse Events Reporting System

enthalten in: Advances in therapy | 2023

von Silberstein, S. | Reshef, S. | Cohen, J. | +6

8

Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System

enthalten in: Advances in therapy | 2022

von Silberstein, S. | Reshef, S. | Cohen, J. | +6

9

Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System

enthalten in: Advances in therapy | 2022

von Silberstein, S. | Reshef, S. | Cohen, J. | +6

10

Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System

enthalten in: Advances in therapy | 2022

von Silberstein, S. | Reshef, S. | Cohen, J. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[50]